Pracinostat

Definition 1

An orally available, small-molecule histone deacetylase (HDAC) inhibitor with potential antineoplastic activity. Pracinostat inhibits HDACs, which may result in the accumulation of highly acetylated histones, followed by the induction of chromatin remodeling; the selective transcription of tumor suppressor genes; the tumor suppressor protein-mediated inhibition of tumor cell division; and, finally, the induction of tumor cell apoptosis. This agent may possess improved metabolic, pharmacokinetic and pharmacological properties compared to other HDAC inhibitors. (NCI Thesaurus)

Definition 2

A substance being studied in the treatment of several types of cancer. SB939 blocks the action of an enzyme called histone deacetylase (HDAC) and may stop tumor cells from dividing. It is a type of HDAC inhibitor. (NCI Dictionary)

YOU MAY ALSO LIKE

PR7V10 (ras-12 Ala) Peptide

A natural or synthetic peptide derived from the Ras protein with potential use in cancer immunotherapy. Ras protein regulates a number of…

PR6V10 (ras-12 Asp) Peptide

A truncated synthetic form of the oncogene Ras, whose protein product p21 is located in the plasma membrane and transduces growth and…

PR18 (ras-13 Cys) Peptide

A truncated synthetic form of the oncogene Ras, whose protein product p21 is located in the plasma membrane and transduces growth and…

PR18 (ras-12CYS) Peptide

A synthetic form of the ras peptide containing a point mutation at position 12 (glycine to cysteine). Vaccines using mutant ras peptides…

PR1 Leukemia Peptide Vaccine

A cancer vaccine containing PR1, a 9 amino-acid human leukocyte antigen (HLA)-A2 restricted peptide derived from proteinase 3, with potential immunotherapeutic…

PR+

Describes cells that have a protein to which the hormone progesterone will bind. Cancer cells that are PR+ need progesterone to grow…